PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Pharmacokinetic Analysis
In brief
A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.
Key facts
- Study ID
- NCT07456800
- Run by
- PureTech
- People needed
- 116
- Starts
- 2021-07-12
- Expected to finish
- 2022-01-20
- Last updated by the study team
- 2026-03-06
Who can join
Age: 60 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Collaborative Neuroscience Network, LLC. — Long Beach, California, United States
- Accel Research Sites — Lake Mary, Florida, United States
- Hassman Research — Berlin, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.